FoundationOne™ Test Registry Study

计划入组 510 人 · 首次发布于 2013 年 5 月 10 日

Concordance Between ctDNA Assay and FoundationOne

计划入组 1,400 人 · 首次发布于 2015 年 12 月 3 日

Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary

计划入组 125 人 · 首次发布于 2015 年 12 月 11 日

Methamidophos

C₂H₈NO₂PS

Niraparib Tosylate/Abiraterone Acetate

Oportuzumab monatox

JEVA LABORATORIES PTY LTD

Australia

VentriPoint Diagnostics Ltd

International Parkside Products Inc

Roche Acquires SAGA Diagnostics for $595M to Enhance Foundation Medicine's Cancer Monitoring Portfolio

FDA Approves FoundationOne CDx and Liquid CDx as Companion Diagnostics for Olaparib Plus Abiraterone in BRCA-Mutated mCRPC

FDA Approves FoundationOne Liquid CDx as Companion Diagnostic for Tepotinib in NSCLC